ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,577.97
0.24%
US Tech 100
19,342.40
0.19%
Dow Jones
40,500.85
0.21%
Brent Oil
80.215
-1.59%
Bitcoin
66,684.70
-1.36%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Kanabo Group Plc (KNB) Quote

Kanabo Group Plc

Kanabo Group Plc (KNB)

Koonenberry gold Ltd
1.30
0.00
(0.00%)
Closed July 23 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.30
Bid
1.20
Ask
1.40
Volume
263,943
1.30 Day's Range 1.30
1.176 52 Week Range 3.05
Market Cap
8.222M
Previous Close
1.30
Open
1.30
Last Trade
177
@
1.2
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
300,053
Shares Outstanding
632,427,870
Dividend Yield
-
PE Ratio
-1.03
Earnings Per Share (EPS)
-0.01
Revenue
895k
Net Profit
-7.99M

About Kanabo Group Plc

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.kanabogroup.com
Headquarters
London, Gbr
Founded
1970
Kanabo Group Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker KNB. The last closing price for Kanabo was 1.30p. Over the last year, Kanabo shares have traded in a share price range of 1.176p to 3.05p.

Kanabo currently has 632,427,870 shares outstanding. The market capitalization of Kanabo is £8.22 million. Kanabo has a price to earnings ratio (PE ratio) of -1.03.

KNB Latest News

More News

Kanabo Group PLC Result of AGM

Kanabo Group PLC 27 June 2024   27 June 2024 Kanabo Group Plc ("Kanabo" or the "Company")   Result of AGM   Kanabo Group Plc (LSE:KNB), a leading health tech company, announces that at the...

June 27 2024
RNS Regulatory News

Kanabo Group PLC Expansion:14 New Clinics Partnership with Treat-It

Kanabo Group PLC 04 June 2024   Kanabo Group Announces Expansion with 14 New Clinics in Partnership with Treat-It London, UK - June 4, 2024 - Kanabo Group, a leading health tech company, is...

June 04 2024
RNS Regulatory News

Kanabo Group PLC Notice of AGM

Kanabo Group PLC 31 May 2024   31 May 2024   Kanabo Group plc ("Kanabo", the "Group" or the "Company")   Notice of Annual General Meeting   Kanabo Group plc (LSE: KNB), the patient focused...

May 31 2024
RNS Regulatory News

Kanabo Group PLC Annual Financial Report

Kanabo Group PLC 30 April 2024         30 April 2024 Kanabo Group Plc ("Kanabo", the "Group" or the "Company")   FULL YEAR RESULTS FOR THE TWELVE MONTHS ENDED 31 DECEMBER 2023   Key highlights...

April 30 2024
RNS Regulatory News

Kanabo Group PLC Expansion of Treat It to Mental Health Treatments

Kanabo Group PLC 28 March 2024     28 March 2024 Kanabo Group Plc ("Kanabo", the "Group" or the "Company")   Expansion of Treat It Clinic to Offer Mental Health Treatments   Kanabo Group plc...

March 28 2024
RNS Regulatory News

Kanabo Group PLC Holding(s) in Company

Kanabo Group PLC 27 March 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYQCS703 Issuer Name KANABO GROUP PLC UK or Non-UK Issuer UK 2. Reason for...

March 27 2024
RNS Regulatory News

Kanabo Group PLC Germany Medical Cannabis Legislation Reform

Kanabo Group PLC 25 March 2024   25 March 2024 Kanabo Group Plc ("Kanabo", the "Group" or the "Company")   Germany's Medical Cannabis Legislation Reform     Kanabo Group plc (LSE: KNB), a...

March 25 2024
RNS Non-Regulatory

Kanabo Group PLC Agritec Update

Kanabo Group PLC 18 March 2024       18 March 2024 Kanabo Group Plc ("Kanabo", the "Group" or the "Company")   Agritec, Marks Milestone in the Medical Cannabis Project   Pursuant to its...

March 18 2024
RNS Regulatory News

Kanabo Group PLC Partnership to launch a Walk-In Pain Clinic

Kanabo Group PLC 15 January 2024 15 January 2024 Kanabo Group Plc ("Kanabo", the "Group" or the "Company") Partnership with City Dock Pharmacy to launch a Walk-In...

January 15 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1-7.142857142861.41.41.32635161.33112324DE
4-0.15-10.34482758621.451.451.292253461.39178932DE
12-0.4-23.52941176471.71.91.293000531.57533527DE
26-0.8-38.09523809522.12.151.294059761.72033417DE
52-0.675-34.17721518991.9753.051.1765437231.86800594DE
156-13.7-91.33333333331525.61.1766894125.45808941DE
260-12.2-90.370370370413.550.751.176119449617.42061102DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
 20.10
(839.25%)
128.72k
RGCRegencell Bioscience Holdings Ltd
$ 10.64
(215.73%)
85.36k
SLRXSalarius Pharmaceuticals Inc
$ 4.2999
(179.21%)
42.77M
ADILAdial Pharmaceuticals Inc
$ 1.7394
(64.09%)
145.29M
SPWRSunPower Corporation
$ 1.0887
(52.10%)
100.18M
RNAZTransCode Therapeutics Inc
$ 0.2998
(-62.17%)
6.02M
JAGXJaguar Health Inc
$ 1.6292
(-61.85%)
9.71M
MIRAMIRA Pharmaceuticals Inc
$ 2.3338
(-53.42%)
19.88M
FLYEFly E Group Inc
$ 3.44
(-46.08%)
6.31M
CMAXCareMax Inc
$ 3.2602
(-37.18%)
7.1M
ADILAdial Pharmaceuticals Inc
$ 1.7394
(64.09%)
145.29M
SPWRSunPower Corporation
$ 1.0887
(52.10%)
100.18M
SLNASelina Hospitality PLC
$ 0.02475
(-33.11%)
94.21M
ATPCAgape ATP Corporation
$ 0.1905
(33.22%)
90.37M
NVDANVIDIA Corporation
$ 123.615
(0.06%)
84.76M

Discussion

View Full Feed
hedge_fun hedge_fun 5 minutes ago
While the SeaSearcher did not see any gold or silver on its initial scan of the Ring Site, it did identify numerous materials including brass, iron, copper, aluminum, lead, and stainless steel.”

https://seafarerexplorationcorp.com/seafarer-announces-second-generation-seasearcher-2/
SFRX
doc2016 doc2016 5 minutes ago
me: does this sound like ploinks and puddle and the creator controls the app and ability to see/use it?
perplexity says:
Performance:
Uses NVIDIA-optimized embedding models for high accuracy
Achieves low latency (around 10ms) for embedding and indexing when used with NV
Hercules1 Hercules1 5 minutes ago
We got that performing monkeys infestation.

It is textbook stuff:

Paid performing monkeys doing their thing.

HIRU
Nihil8 Nihil8 5 minutes ago
James Bond strikes again
CNNA
theorysuit theorysuit 6 minutes ago
I can't wait for whatever PUMP PR they put for this final pump and dump. It is going to be some laughable comedy that is justifed by the ihub pumpers.
NWBO
tapioca tapioca 6 minutes ago
What the hell are you talking about. "Kitty cat short squeeze",
useless.
RNAZ
otcsource otcsource 6 minutes ago
Nobody cares! The same old news over and over again. Employees fine make the company private and pay them more.
KEGS
georgejjl georgejjl 6 minutes ago
Institutions are helping the upward price move for AVXL stock. The financial institutions have been and are continuing to buy AVXL today.

Good luck and GOD bless,
AVXL
Carjockey2 Carjockey2 6 minutes ago
https://x.com/cocomoco1234567/status/1815780156016930896?t=ob1Wr9VUqHUDnPv04IatRw&s=19

Lolzzzz
HIRU
Chester100 Chester100 7 minutes ago
Still here I see 👀
FUNN
otcsource otcsource 7 minutes ago
NO, Seriously nobody cares. Regurgitation of the same old news. Nobody cares.
KEGS
ilovetech ilovetech 7 minutes ago
Also important to keep in mind, how long new regulatory guidance took to establish RWE as viable, and or even preferable, from an ethical perspective for severe disease trials, which helps the recruiting efforts to enroll trial participants. Also keep in mind, that it was the regulators who required
NWBO
drkazmd65 drkazmd65 8 minutes ago
Interesting move up this morning - volume is kind of light though for it to seem like anything 'real' is up.
CVM
just Scottie just Scottie 8 minutes ago
You were saying!
KITL
Chromosome Chromosome 8 minutes ago
Eagerly waiting Captains UK numbers but not knowing the full U.K. holiday schedule and all things being equal, looks like there are three fewer working days in June vs May. Add the typical summer slowdown, appropriate calibration may be in order.
AMRN
SloGin SloGin 8 minutes ago
Explain..(your comment)!!!

Direct from the favorite guy you guys love to bash & twist facts just posted on X

Yup the same one who brought the Australia Sheikh deal to $HIRU & HIRU backer / equipment financiers

https://tinyurl.com/4zna98a6
HIRU
Acme Investments Acme Investments 8 minutes ago
Reminds me of the first hill of the roller-coaster 🎢!! Tick...tick....tick....then drop!!
HIRU
somberfox somberfox 9 minutes ago
We're getting a watch man. Chilll.
RONN
JJZander JJZander 9 minutes ago
We’ve now registered Synbio International Inc with the authorities in Florida. Just waiting on FINRA to approve the new ticker before using our new name. New name, new funding, new business. Looking forward to building value for the long-suffering shareholders of NHYF.
NHYF
B_B! B_B! 9 minutes ago
I think the Russell 2000 will double its gains today and save AMC.
AMC
BullNBear52 BullNBear52 9 minutes ago
I doubt the vet will let you have a cow. With my ailments I can eat anything and I feel sorry for what you must be going through.

Not sure I could do that.
martyDg martyDg 9 minutes ago
No matter how revolutionary this is, all of this doesn't matter if the RA doesn't approve the vaccine. No matter how good it looks on paper, if the RA says no, then what are you going to do?
NWBO

Your Recent History

LSE
KNB
Kanabo
BOV
IGTI11F
Iguatemi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved